Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Matthews

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Frontiers in Immunology|July 2, 2021
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient ResponsesGeorgia Bullen, Jacob D Galson, Gareth Hall, et al.
Journal of Medicinal Chemistry|December 15, 2021
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical TargetCaroline Wilson, Peter Ray, Fabio Zuccotto, et al.
Diabetes|January 10, 2013
Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from IndiaRicha Saxena, Danish Saleheen, Latonya F Been, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitroTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Frontiers in Immunology|July 2, 2021
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient ResponsesGeorgia Bullen, Jacob D Galson, Gareth Hall, et al.
Journal of Medicinal Chemistry|December 15, 2021
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical TargetCaroline Wilson, Peter Ray, Fabio Zuccotto, et al.
Diabetes|January 10, 2013
Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from IndiaRicha Saxena, Danish Saleheen, Latonya F Been, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitroTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 12